Predictive Factors for Ovarian Stimulation Using a Fixed Daily Dose of 200 IU Recombinant FSH (Study 142003)(P05696)

NCT00778999 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
442
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Organon and Co